Skip to main content

Table 1 Correlation between TUBA4B expression and clinicopathological features in GC patients (n = 83)

From: RETRACTED ARTICLE: LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b

Parameters

All cases

TUBA4B expression

p value

Low (n = 42)

High (n = 41)

Gender

 Male

63

31

32

0.652

 Female

20

11

9

Age (years)

 ≤ 60

31

17

14

0.551

 > 60

52

25

27

Tumor size

 ≤ 5

45

18

27

0.036

 > 5

38

24

14

Lymph node metastasis

 No

39

13

26

0.003

 Yes

44

29

15

TNM stage

 I–II

36

11

25

0.001

 III–IV

47

31

16

Differentiation grade

 Well/moderate

43

19

24

0.225

 Poor

40

23

17

  1. TNM stage was based on the 8th edition American Joint Committee on Cancer (AJCC) staging
  2. Italic values indicate significance of p value (p < 0.05)